Literature DB >> 15066185

World of small RNAs: from ribozymes to siRNA and miRNA.

Hiroaki Kawasaki1, Renu Wadhwa, Kazunari Taira.   

Abstract

RNAs, besides bridging genetic information to proteins, the major determinants of bio-structures and functions, serve as active regulators of gene expression. Initiated nearly 20 years ago with ribozymes (the small RNAs with catalytic activity providing fine tuning of gene expression and function, used as molecular scissors and tools for gene discovery), an era of more complex and coordinated gene regulation by small RNAs, siRNA, and miRNA has recently started. Simple nucleotide complementarity results in highly ordered and regulated events, such as assembly of RNA and proteins, resulting in gene silencing either by mRNA degradation or suppression of translation. This article reviews our contributions to the understanding of structure, the function of small RNAs, their use in biotechnology, and the understanding of phenotypes such as apoptosis, metastasis, and differentiation.

Mesh:

Substances:

Year:  2004        PMID: 15066185     DOI: 10.1111/j.1432-0436.2004.07202006.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  11 in total

1.  Are viral-encoded microRNAs mediating latent HIV-1 infection?

Authors:  Marc S Weinberg; Kevin V Morris
Journal:  DNA Cell Biol       Date:  2006-04       Impact factor: 3.311

2.  "Genome design" model: evidence from conserved intronic sequence in human-mouse comparison.

Authors:  Alexander E Vinogradov
Journal:  Genome Res       Date:  2006-02-03       Impact factor: 9.043

3.  Light-activation of gene function in mammalian cells via ribozymes.

Authors:  Douglas D Young; R Aaron Garner; Jeffrey A Yoder; Alexander Deiters
Journal:  Chem Commun (Camb)       Date:  2008-12-02       Impact factor: 6.222

4.  An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease.

Authors:  Reiko Onuki; Yoshio Bando; Eigo Suyama; Taiichi Katayama; Hiroaki Kawasaki; Tadashi Baba; Masaya Tohyama; Kazunari Taira
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

5.  Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy.

Authors:  Xin Wu; Baoyue Ding; Jing Gao; Huanyun Wang; Wei Fan; Xiang Wang; Wei Zhang; Xiaoyu Wang; Lihua Ye; Min Zhang; Xueying Ding; Jiyong Liu; Quangang Zhu; Shen Gao
Journal:  Int J Nanomedicine       Date:  2011-08-19

Review 6.  Smart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapy.

Authors:  Lukas J Aaldering; Hossam Tayeb; Shilpa Krishnan; Susan Fletcher; Stephen D Wilton; Rakesh N Veedu
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 7.  Methods for Using Small Non-Coding RNAs to Improve Recombinant Protein Expression in Mammalian Cells.

Authors:  Sarah Inwood; Michael J Betenbaugh; Joseph Shiloach
Journal:  Genes (Basel)       Date:  2018-01-09       Impact factor: 4.096

8.  miR-181a Modulates Chondrocyte Apoptosis by Targeting Glycerol-3-Phosphate Dehydrogenase 1-Like Protein (GPD1L) in Osteoarthritis.

Authors:  Xicheng Zhai; Ru Meng; Hongbiao Li; Jie Li; Lei Jing; Lei Qin; Yulei Gao
Journal:  Med Sci Monit       Date:  2017-03-10

9.  Selective silencing of DNA topoisomerase IIβ in human mesenchymal stem cells by siRNAs (small interfering RNAs).

Authors:  Nebiyyeh Kamaci; Tuba Emnacar; Nihal Karakas; Gulsum Arikan; Ken Tsutsui; Sevim Isik
Journal:  Cell Biol Int Rep (2010)       Date:  2011-04-26

Review 10.  Chromatin, non-coding RNAs, and the expression of HIV.

Authors:  Jessica N Groen; Kevin V Morris
Journal:  Viruses       Date:  2013-06-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.